Section 119402 of the California Health and Safety Code requires a pharmaceutical company to adopt a Comprehensive Compliance Program that is in accordance with the US Department of Health and Human Services, Office of Inspector General's "Compliance Program Guidance for Pharmaceutical Manufacturers", and include policies for complying with the Pharmaceutical Research and Manufacturers of America Code.
Further, the law requires that the Comprehensive Compliance Program include an annual limit for certain items and activities given to healthcare professionals covered by this California law.
Finally, the law requires that each manufacturer make its Comprehensive Compliance Program and an annual declaration of compliance publicly available.
The following PDFs open in a new tab.
To view PDF documents you may need to install Adobe Reader. PDF links on this site open in a new tab.